LivaNova (LIVN) Liabilities and Shareholders Equity (2015 - 2026)
LivaNova's (LIVN) quarterly Liabilities and Shareholders Equity came in at $2.5 billion in Q1 2026, down 1.66% year-on-year from $2.6 billion in Q1 2025, and down 3.44% quarter-over-quarter from $2.6 billion in Q4 2025.
LivaNova (LIVN) Liabilities and Shareholders Equity (2015 - 2026) Analysis & Trends
LivaNova has disclosed Liabilities and Shareholders Equity across 12 years of filings, most recently posting $2.5 billion for Q1 2026.
- Liabilities and Shareholders Equity for Q1 2026 came in at $2.5 billion, down 1.66% year-over-year; the trailing twelve-month figure through Mar 2026 was $10.2 billion (up 20.66% YoY), and the FY2025 annual result was $2.6 billion, up 3.98% from the prior year.
- Liabilities and Shareholders Equity came in at $2.5 billion for Q1 2026 at LivaNova, down from $2.6 billion in the prior quarter.
- In the past five years, Liabilities and Shareholders Equity ranged from a high of $2.6 billion in Q4 2025 to a low of $855.1 million in Q2 2024.
- The 5-year median for Liabilities and Shareholders Equity is $2.4 billion (2023), against an average of $2.3 billion.
- Across the five-year window, Liabilities and Shareholders Equity sank 63.48% in 2024 and surged 193.15% in 2025, its largest moves.
- LivaNova's Liabilities and Shareholders Equity stood at $2.3 billion in 2022, then climbed by 5.87% to $2.4 billion in 2023, then increased by 3.16% to $2.5 billion in 2024, then climbed by 3.98% to $2.6 billion in 2025, then declined by 3.44% to $2.5 billion in 2026.
- The last three Liabilities and Shareholders Equity figures came in at $2.5 billion (Q1 2026), $2.6 billion (Q4 2025), and $2.6 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 110.43 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 46.29 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 91.49 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 13.32 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 31.92 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 6.63 Bn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 37.13 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 10.74 Bn |
| 10 | LivaNova | 4.29 Bn | 3.71 Bn | 243.75 Mn | 2.52 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.52 Bn |
| Dec 31, 2025 | 2.61 Bn |
| Sep 30, 2025 | 2.56 Bn |
| Jun 30, 2025 | 2.51 Bn |
| Mar 31, 2025 | 2.56 Bn |
| Dec 31, 2024 | 2.51 Bn |
| Sep 30, 2024 | 2.52 Bn |
| Jun 30, 2024 | 855.10 Mn |
| Mar 31, 2024 | 2.46 Bn |
| Dec 31, 2023 | 2.43 Bn |
| Sep 30, 2023 | 2.33 Bn |
| Jun 30, 2023 | 2.34 Bn |
| Mar 31, 2023 | 2.29 Bn |
| Dec 31, 2022 | 2.29 Bn |
| Sep 30, 2022 | 2.21 Bn |
| Jun 30, 2022 | 2.34 Bn |
| Mar 31, 2022 | 2.42 Bn |
| Dec 31, 2021 | 2.20 Bn |
| Sep 30, 2021 | 2.20 Bn |
| Jun 30, 2021 | 2.40 Bn |